Details of the Drug Reposition

General Information of This Drug (ID: DM264B3)

Drug Name
Dimenhydrinate   DM264B3
Synonyms
Gravamin (TN); Gravol (TN); Vertirosan (TN); Dimenhydrinate (JP15/USP/INN); 2-(diphenylmethoxy)-N,N-dimethylethanaminium 8-chloro-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropurin-7-ide; 2-benzhydryloxyethyl(dimethyl)azanium; 8-chloro-1,3-dimethyl-2-oxopurin-6-olate; 8-chloro-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione-2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1)
Therapeutic Class
Antiemetics
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Meniere disease DISC5R5F AB31.0 Approved [1]
Vomiting DISDOA71 MD90 Approved [1]
------------------------------------------------------------------------------------
1 Withdrawn Indication(s)
Indication Name Indication ID ICD-11 Status REF
Motion sickness DISZ2WZW NF08.3 Withdrawn [2]
------------------------------------------------------------------------------------

References

1 Dimenhydrinate FDA Label
2 ClinicalTrials.gov (NCT01000896) Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and Paclitaxel